国家医保局：新版基本医保药品目录拟12月首周公布

Core Points - The National Healthcare Security Administration (NHSA) announced that the new basic medical insurance drug list and the first version of the commercial insurance innovative drug list will be released online and offline in Guangzhou on the first weekend of December, with implementation starting January 1, 2024 [1] - The negotiation for the basic medical insurance drug list concluded on November 3, with 120 domestic and foreign companies participating, including 127 drugs outside the list and 24 drugs for the commercial insurance innovative drug list [3] - The commercial insurance innovative drug list was established to better meet the diverse medication needs of the public, with 121 high-value drugs approved through this new list [3][7] Industry Insights - The commercial health insurance market in China is experiencing rapid growth, with the original insurance premium income for commercial health insurance reaching 977.3 billion yuan in 2024, a year-on-year increase of 8.2% [7] - The total expenditure of the basic medical insurance fund is projected to reach 2.97 trillion yuan in 2024, providing solid support for public healthcare [7] - The NHSA is working to address challenges in synchronizing medical insurance and commercial insurance settlements, with initiatives like the establishment of a national "medical insurance + commercial insurance" clearing settlement center in Beijing [9]